Year |
Citation |
Score |
2022 |
Kang CS, Zhang S, Wang H, Liu Y, Ren S, Chen Y, Li J, Bandara N, Rogachev AY, Rogers BE, Chong HS. Novel Chelating Agents for Zirconium-89-Positron Emission Tomography (PET) Imaging: Synthesis, DFT Calculation, Radiolabeling, and and Complex Stability. Acs Omega. 7: 37229-37236. PMID 36312419 DOI: 10.1021/acsomega.2c03478 |
0.682 |
|
2021 |
Chong HS, Chen Y, Kang CS, Sin I, Zhang S, Wang H. Pyridine-containing octadentate ligand NE3TA-PY for formation of neutral complex with Lu(III) and Y(III) for radiopharmaceutical applications: Synthesis, DFT calculation, radiolabeling, and in vitro complex stability. Journal of Inorganic Biochemistry. 221: 111436. PMID 33971521 DOI: 10.1016/j.jinorgbio.2021.111436 |
0.692 |
|
2020 |
Sun X, Kang CS, Sin I, Zhang S, Ren S, Wang H, Liu D, Lewis MR, Chong HS. New Bifunctional Chelator 3p--NEPA for Potential Applications in Lu(III) and Y(III) Radionuclide Therapy and Imaging. Acs Omega. 5: 28615-28620. PMID 33195913 DOI: 10.1021/acsomega.0c03551 |
0.699 |
|
2019 |
Jang JH, Han SJ, Kim JY, Kim KI, Lee KC, Kang CS. Synthesis and Feasibility Evaluation of a new Trastuzumab Conjugate Integrated with Paclitaxel and Zr for Theranostic Application Against HER2-Expressing Breast Cancers. Chemistryopen. 8: 451-456. PMID 31008009 DOI: 10.1002/Open.201900037 |
0.336 |
|
2018 |
Ren S, Sun X, Wang H, Nguyen TH, Sadeghipour N, Xu X, Kang CS, Liu Y, Xu H, Wu N, Chen Y, Tichauer K, Minh DDL, Chong H. Front Cover: Design, Synthesis, and Biological Evaluation of Polyaminocarboxylate Ligand-Based Theranostic Conjugates for Antibody-Targeted Cancer Therapy and Near-Infrared Optical Imaging (ChemMedChem 24/2018) Chemmedchem. 13: 2599-2599. DOI: 10.1002/Cmdc.201800767 |
0.696 |
|
2016 |
Kang CS, Ren S, Sun X, Chong HS. Theranostic Polyaminocarboxylate-Cyanine-Transferrin Conjugate for Anticancer Therapy and Near-Infrared Optical Imaging. Chemmedchem. PMID 27624789 DOI: 10.1002/Cmdc.201600072 |
0.673 |
|
2016 |
Jeong K, Park S, Lee YD, Kang CS, Kim HJ, Park H, Kwon IC, Kim J, Park CR, Kim S. Size-engineered biocompatible polymeric nanophotosensitizer for locoregional photodynamic therapy of cancer. Colloids and Surfaces. B, Biointerfaces. 144: 303-310. PMID 27107384 DOI: 10.1016/J.Colsurfb.2016.04.029 |
0.338 |
|
2016 |
Jeong K, Kang CS, Kim Y, Lee YD, Kwon IC, Kim S. Development of highly efficient nanocarrier-mediated delivery approaches for cancer therapy. Cancer Letters. PMID 26854717 DOI: 10.1016/J.Canlet.2016.01.050 |
0.33 |
|
2016 |
Jeong K, Kim Y, Kang CS, Cho HJ, Lee YD, Kwon IC, Kim S. Nanoprobes for optical bioimaging Optical Materials Express. 6: 1262-1279. DOI: 10.1364/Ome.6.001262 |
0.317 |
|
2015 |
Sun X, Chen Y, Wu N, Kang CS, Song HA, Jin S, Fu Y, Bryant H, Frank JA, Chong HS. Application of aziridinium ring opening for preparation of optically active diamine and triamine analogues: Highly efficient synthesis and evaluation of DTPA-based MRI contrast enhancement agents. Rsc Advances. 5: 94571-94581. PMID 26989478 DOI: 10.1039/C5Ra11306G |
0.657 |
|
2015 |
Wu N, Kang CS, Sin I, Ren S, Liu D, Ruthengael VC, Lewis MR, Chong HS. Promising bifunctional chelators for copper 64-PET imaging: practical (64)Cu radiolabeling and high in vitro and in vivo complex stability. Journal of Biological Inorganic Chemistry : Jbic : a Publication of the Society of Biological Inorganic Chemistry. PMID 26666778 DOI: 10.1007/S00775-015-1318-7 |
0.735 |
|
2015 |
Kang CS, Wu N, Chen Y, Sun X, Bandara N, Liu D, Lewis MR, Rogers BE, Chong HS. Transferrin conjugates of triazacyclononane-based bifunctional NE3TA chelates for PET imaging: Synthesis, Cu-64 radiolabeling, and in vitro and in vivo evaluation. Journal of Inorganic Biochemistry. 154: 60-66. PMID 26583705 DOI: 10.1016/J.Jinorgbio.2015.10.012 |
0.712 |
|
2015 |
Chong HS, Chen Y, Kang CS, Sun X, Wu N. Novel (64)Cu-radiolabeled bile acid conjugates for targeted PET imaging. Bioorganic & Medicinal Chemistry Letters. 25: 1082-5. PMID 25661712 DOI: 10.1016/J.Bmcl.2015.01.008 |
0.691 |
|
2015 |
Chong HS, Sun X, Chen Y, Sin I, Kang CS, Lewis MR, Liu D, Ruthengael VC, Zhong Y, Wu N, Song HA. Synthesis and comparative biological evaluation of bifunctional ligands for radiotherapy applications of (90)Y and (177)Lu. Bioorganic & Medicinal Chemistry. 23: 1169-78. PMID 25648683 DOI: 10.1016/J.Bmc.2014.12.035 |
0.748 |
|
2015 |
Kang CS, Chen Y, Lee H, Liu D, Sun X, Kweon J, Lewis MR, Chong HS. Synthesis and evaluation of a new bifunctional NETA chelate for molecular targeted radiotherapy using(90)Y or(177)Lu. Nuclear Medicine and Biology. 42: 242-9. PMID 25487552 DOI: 10.1016/J.Nucmedbio.2014.10.004 |
0.722 |
|
2015 |
Sun X, Chen Y, Wu N, Kang CS, Song HA, Jin S, Fu Y, Bryant H, Frank JA, Chong HS. Application of aziridinium ring opening for preparation of optically active diamine and triamine analogues: highly efficient synthesis and evaluation of DTPA-based MRI contrast enhancement agents Rsc Advances. 5: 94571-94581. DOI: 10.1039/c5ra11306g |
0.642 |
|
2015 |
Kang CS, Chen Y, Dadachova E, Chong HS. Evaluation of benzyl-substituted DTPA analogues as decorporation agents of radionuclides Journal of Radioanalytical and Nuclear Chemistry. 303: 2407-2411. DOI: 10.1007/S10967-014-3714-9 |
0.362 |
|
2014 |
Sin I, Kang CS, Bandara N, Sun X, Zhong Y, Rogers BE, Chong HS. Novel hexadentate and pentadentate chelators for â¶â´Cu-based targeted PET imaging. Bioorganic & Medicinal Chemistry. 22: 2553-62. PMID 24657050 DOI: 10.1016/J.Bmc.2014.02.041 |
0.7 |
|
2014 |
Chong HS, Sun X, Zhong Y, Bober K, Lewis MR, Liu D, Ruthengael VC, Sin I, Kang CS. Synthesis and evaluation of an enantiomerically enriched bifunctional chelator for 64Cu-based positron emission tomography (PET) imaging European Journal of Organic Chemistry. 2014: 1305-1313. DOI: 10.1002/Ejoc.201301499 |
0.731 |
|
2013 |
Kang CS, Song HA, Milenic DE, Baidoo KE, Brechbiel MW, Chong HS. Preclinical evaluation of NETA-based bifunctional ligand for radioimmunotherapy applications using 212Bi and 213Bi: radiolabeling, serum stability, and biodistribution and tumor uptake studies. Nuclear Medicine and Biology. 40: 600-5. PMID 23541026 DOI: 10.1016/J.Nucmedbio.2013.01.012 |
0.747 |
|
2012 |
Kang CS, Sun X, Jia F, Song HA, Chen Y, Lewis M, Chong HS. Synthesis and preclinical evaluation of bifunctional ligands for improved chelation chemistry of 90Y and 177Lu for targeted radioimmunotherapy. Bioconjugate Chemistry. 23: 1775-82. PMID 22881720 DOI: 10.1021/Bc200696B |
0.748 |
|
2012 |
De Silva RA, Jain S, Lears KA, Chong HS, Kang CS, Sun X, Rogers BE. Copper-64 radiolabeling and biological evaluation of bifunctional chelators for radiopharmaceutical development. Nuclear Medicine and Biology. 39: 1099-104. PMID 22743158 DOI: 10.1016/J.Nucmedbio.2012.05.009 |
0.708 |
|
2011 |
Chong HS, Sun X, Dong P, Kang CS. Convenient Synthesis and Evaluation of Heptadentate Bifunctional Ligand for Radioimmunotherapy Applications. European Journal of Organic Chemistry. 2011: 6641-6648. PMID 23794941 DOI: 10.1002/Ejoc.201101063 |
0.72 |
|
2011 |
Dadwal M, Kang CS, Song HA, Sun X, Dai A, Baidoo KE, Brechbiel MW, Chong HS. Synthesis and evaluation of a bifunctional chelate for development of Bi(III)-labeled radioimmunoconjugates. Bioorganic & Medicinal Chemistry Letters. 21: 7513-5. PMID 22047687 DOI: 10.1016/J.Bmcl.2011.06.107 |
0.741 |
|
2011 |
Song HA, Kang CS, Baidoo KE, Milenic DE, Chen Y, Dai A, Brechbiel MW, Chong HS. Efficient bifunctional decadentate ligand 3p-C-DEPA for targeted α-radioimmunotherapy applications. Bioconjugate Chemistry. 22: 1128-35. PMID 21604692 DOI: 10.1021/Bc100586Y |
0.747 |
|
2011 |
Chong HS, Song HA, Kang CS, Le T, Sun X, Dadwal M, Lee H, Lan X, Chen Y, Dai A. A highly effective bifunctional ligand for radioimmunotherapy applications. Chemical Communications (Cambridge, England). 47: 5584-6. PMID 21468393 DOI: 10.1039/C0Cc05707J |
0.738 |
|
2011 |
Chong H, Sun X, Dong P, Kang CS. Convenient Synthesis and Evaluation of a Heptadentate Bifunctional Ligand for Radioimmunotherapy Applications (Eur. J. Org. Chem. 33/2011) European Journal of Organic Chemistry. 2011: n/a-n/a. DOI: 10.1002/Ejoc.201190094 |
0.715 |
|
Show low-probability matches. |